Crystal Growth & Design
Page 24 of 26
1
2
3
4
5
6
7
8
9
14. Wen, G. L.; Wang, Y. Y.; Zhang, W. H.; Ren, C.; Liu, R. T.; Shi, Q. Z., Selfꢀassembled
coordination polymers of Vꢀshaped bis(pyridyl)thiadiazole dependent upon the spacer length
and flexibility of aliphatic dicarboxylate ligands. Crystengcomm 2010, 12 (4), 1238ꢀ1251.
15. Panini, P.; Mohan, T. P.; Gangwar, U.; Sankolli, R.; Chopra, D., Quantitative crystal structure
analysis of 1,3,4ꢀthiadiazole derivatives. CrystEngComm 2013, 15 (22), 4549ꢀ4564.
16. Hoser, A. A.; Kaminski, D. M.; Matwijczuk, A.; Niewiadomy, A.; Gagos, M.; Wozniak, K.,
On polymorphism of 2ꢀ(4ꢀfluorophenylamino)ꢀ5ꢀ(2,4ꢀdihydroxybenzeno)ꢀ1,3,4ꢀthiadiazole
(FABT) DMSO solvates. CrystEngComm 2013, 15 (10), 1978ꢀ1988.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
17. Kaminski, D. M.; Hoser, A. A.; Gagos, M.; Matwijczuk, A.; Arczewska, M.; Niewiadomy,
A.; Wozniak, K., Solvatomorphism of 2ꢀ(4ꢀFluorophenylamino)ꢀ5ꢀ(2,4ꢀdihydroxybenzeno)ꢀ
1,3,4ꢀthiadiazole Chloride. Crystal Growth & Design 2010, 10 (8), 3480ꢀ3488.
18. Kaminski, D. M.; Matwijczuk, A.; Pociecha, D.; Gorecka, E.; Niewiadomy, A.; Dmowska,
M.; Gagos, M., Effect of 2ꢀ(4ꢀfluorophenylamino)ꢀ5ꢀ(2,4ꢀdihydroxyphenyl)ꢀ1,3,4ꢀthiadiazole
on the molecular organisation and structural properties of the DPPC lipid multibilayers. Bba-
Biomembranes 2012, 1818 (11), 2850ꢀ2859.
19. Menchise, V.; De Simone, G.; Di Fiore, A.; Scozzafava, A.; Supuran, C. T., Carbonic
anhydrase inhibitors: Xꢀray crystallographic studies for the binding of 5ꢀaminoꢀ1,3,4ꢀ
thiadiazoleꢀ2ꢀsulfonamide
and
5ꢀ(4ꢀaminoꢀ3ꢀchloroꢀ5ꢀfluorophenylsulfonamido)1,3,4ꢀ
thiadiazoleꢀ2ꢀsulfonamide to human isoform II. Bioorg Med Chem Lett 2006, 16 (24), 6204ꢀ
6208;
20. Temperini, C.; Cecchi, A.; Boyle, N. A.; Scozzafava, A.; Escribano Cabeza, J.; Wentworth, P.;
Blackburn, G. M.; Supuran, C. T., Carbonic anhydrase inhibitors. Interaction of 2ꢀN,Nꢀ
dimethylaminoꢀ1,3,4ꢀthiadiazoleꢀ5ꢀmethanesulfonamide with 12 mammalian isoforms:
Kinetic and Xꢀray crystallographic studies. Bioorg Med Chem Lett 2008, 18 (3), 999ꢀ1005.
21. Etter, M. C., Encoding and decoding hydrogenꢀbond patterns of organicꢀcompounds.
Accounts of Chemical Research 1990, 23 (4), 120ꢀ126.
22. Bilton C., Allen F. H., Shields G. P., Howard J. A. K. Intramolecular hydrogen bonds:
common motifs, probabilities of formation and implications for supramolecular organization.
Acta Cryst. 2000, B56, 849-856
23. GonzálezꢀGonzález J. S., MartínezꢀMartínez F. J., GarcíaꢀBáez E.V., Cruz A., MorínꢀSánchez
L. M., RojasꢀLima S., PadillaꢀMartínez I. I. Molecular Complexes of Diethyl N,N′ 1,3ꢀ
Phenyldioxalamate and Resorcinols: Conformational Switching through Intramolecular
ThreeꢀCentered HydrogenꢀBonding. Cryst. Growth Des. 2014, 14, 628−642
24. Mukherjee A.,
Grobelny P., Thakur T. S., Desiraju G. R. Polymorphs,
Pseudopolymorphs, and CoꢀCrystals of Orcinol: Exploring the Structural Landscape
with High Throughput Crystallography. Cryst. Growth Des. 2011, 11, 2637–2653
25. Ton Q.ꢀC., Michael Bolte 2,6ꢀDiacetylpyridine–resorcinol (1/1) Acta Cryst. 2012, E68, o2699
26. Skrzypek, A.; Matysiak, J.; Niewiadomy, A.; Bajda, M.; Szymanski, P., Synthesis and
biological evaluation of 1,3,4ꢀthiadiazole analogues as novel AChE and BuChE inhibitors.
Eur J Med Chem 2013, 62, 311ꢀ319;
27. Matysiak, J., Synthesis of 5ꢀsubstituted 2ꢀ(2,4ꢀdihydroxyphenyl)ꢀ1,3,4ꢀthiadiazoles. J
Heterocyclic Chem 2006, 43 (1), 55ꢀ58;
28. Matysiak, J.; Nasulewicz, A.; Pelczynska, M.; Switalska, M.; Jaroszewicz, I.; Opolski, A.,
Synthesis and antiproliferative activity of some 5ꢀsubstituted 2ꢀ(2,4ꢀdihydroxyphenyl)ꢀ1,3,4ꢀ
thiadiazoles. Eur J Med Chem 2006, 41 (4), 475ꢀ482.
29. Niewiadomy, A.; Matysiak, J.; G, M.ꢀN. Nowe tioamidy, produkt pośredni do otrzymywania
nowych tioamidów. 2000.
30. CrysAlis CCD and CrysAlis RED, Oxford Diffraction, Oxford Diffraction Ltd, Yarnton 2008.
31. Sheldrick, G. M., A short history of SHELX. Acta Cryst.A 2008, 64, 112ꢀ122.
32. SMART and SAINTPLUS - Area Detector Control and Integration Software, version 6.01,
Bruker AXS: Madison, WI, 1999.
24
ACS Paragon Plus Environment